Daniel Keleti, M.D.
Radiation Oncology Physician in Blue Springs, Missouri. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 6,018 in Radiation Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Daniel Keleti, M.D. reported a CMS MIPS final score of 91.9/100 — above the 83.1 national average — and filed 538 Medicare Part D claims in 2023.
- 91.9/100
- MIPS score · +9 vs avg
- 538
- Part D claims, 2023
- 78%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
Daniel Keleti, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
92 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Daniel Keleti, M.D. sits
This provider among radiation oncology physician peers
Across the 1,988 radiation oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Daniel Keleti, M.D. writes more Part D claims than 97% of them and scores higher on MIPS quality than 65% — placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one radiation oncology physician peer from a representative sample of 60; the gold marker is Daniel Keleti, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Daniel Keleti, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Keleti, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Missouri
How Radiation Oncology Physician compares to other specialties among Missouri providers
Largest specialties in Missouri (% of in-state providers)
Radiation Oncology Physician ranks #91 among Missouri's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Missouri provider total, by primary NUCC taxonomy. The highlighted bar is Radiation Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance — MIPS
Daniel Keleti, M.D.'s 2023 MIPS final score plotted against the Radiation Oncology Physician national average
- MIPS Final Score
- 91.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Radiation Oncology Physician) — 91.9/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Radiation Oncology Physician US NPIs
91.9/100 MIPS final score — 8.8 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Radiation Oncology Physician. Quality dim: 75.2.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Daniel Keleti, M.D. appears in the CMS NPPES registry as a Radiation Oncology Physician provider holding M.D. credentials at 300 NW MOCK AVE, Blue Springs, MO, 64014, with a listed phone of (816) 655-5592. NPI 1356325245 was issued on 12/04/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Keleti most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 538 prescription claims written by this provider, covering 164 Medicare beneficiaries and totaling roughly $10K in drug spend, split 15% brand-name and 78% generic by claim count, with an opioid prescribing rate of 16.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.9/100 for the 2023 performance year (Quality 75.2), compared with the national average of 83.1.
Radiation Oncology Physician is a mid-sized specialty nationwide, with 6,018 enrolled providers across 52 states and an average of 186 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1356325245 |
|---|---|
| Specialty | Radiation Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 12/04/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Daniel Keleti, M.D.'s current license status, disciplinary history, and board certifications with the Missouri Board of Registration for the Healing Arts in Missouri before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Daniel Keleti, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Keleti, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$63
Largest payer
Merck Sharp & Dohme LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
15% brand-name claims vs 78% generic, on 538 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 868
- Total Day Supply
- 20,427
- Brand vs Generic
- 15% brand / 78% generic
- Brand Drug Cost
- $2K
- Generic Drug Cost
- $7K
- Opioid Claims
- 88 (16.4% rate)
- Antibiotic Claims
- 28
Patient Demographics
- Average Patient Age
- 72.8 years
- Avg HCC Risk Score
- 2.06
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 14, 65-74: 89, 75-84: 50, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Daniel Keleti, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
116 claims
- Tramadol Hcl 34
Tramadol Hcl
34 claims
- Oxycodone Hcl 29
Oxycodone Hcl
29 claims
- Lidocaine Hcl Visc… 28
Lidocaine Hcl Viscous
28 claims
- Tamsulosin Hcl 24
Tamsulosin Hcl
24 claims
- Sodium Fluoride 21
Sodium Fluoride
21 claims
- Azithromycin 19
Azithromycin
19 claims
- Dexamethasone 19
Dexamethasone
19 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 116 |
| Tramadol Hcl | 34 |
| Oxycodone Hcl | 29 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 28 |
| Tamsulosin Hcl | 24 |
| Sodium Fluoride Fluoride (Sodium) | 21 |
| Azithromycin | 19 |
| Dexamethasone | 19 |
| Ondansetron Hcl | 19 |
| Silver Sulfadiazine | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Radiation Oncology Physician Overview
How Daniel Keleti, M.D. fits within the Radiation Oncology Physician landscape nationally.
Daniel Keleti, M.D.'s 538 claims are above the specialty average of 186.
Nearby Radiation Oncology Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Keleti.
Compare Radiation Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Missouri medical board — federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Radiation Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Missouri
Frequently Asked Questions
What is Daniel Keleti, M.D.'s specialty? ▼
How much does Daniel Keleti, M.D. prescribe under Medicare Part D? ▼
What is Daniel Keleti, M.D.'s Medicare quality score? ▼
Where is Daniel Keleti, M.D. located? ▼
What is Daniel Keleti, M.D.'s NPI number? ▼
Does Daniel Keleti, M.D. prescribe more brand-name or generic drugs? ▼
Does Daniel Keleti, M.D. prescribe opioids? ▼
How many Radiation Oncology Physician providers are there in the US? ▼
What drugs does Daniel Keleti, M.D. prescribe most often? ▼
Does Daniel Keleti, M.D. accept Medicare? ▼
How can I verify Daniel Keleti, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology